ADVANCED TISSUE SCIENCES' DERMAGRAFT-TC NEEDS POSTMARKET SURVEILLANCE STUDY; TEMPORARY COVERING FOR SEVERE BURNS APPROVABLE, FDA PANEL CONCLUDES
This article was originally published in The Gray Sheet
Advanced Tissue Sciences' Dermagraft-TC temporary skin replacement should be approved for treatment of full-thickness and deep partial-thickness burns, FDA's General and Plastic Surgery Devices Panel concluded at a Nov. 19 meeting in Gaithersburg, Maryland.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.